Doseresponse curves were generated at equilibrium (10 min) and EC 50 values were calculated from this
While both agents struggled with the inherent GI burden typical of GLP-1RAs, efpeglenatides limitations were largely dose-related and within manageable expectations, whereas taspoglutides combination of severe immunogenicity and hypersensitivity reactions rendered it clinically unviable
If you are switching from semaglutide to retatrutide, the full comparison between the two peptides helps you understand what changes to expect
Our team includes experienced master artist injectors, and our providers experience spans: Heidi, PA-C (15 years), Alicia, PA-C (10 years), Katie, NP-BC (7 years), Joni, RN (5 years), Tiffany, PA-C (5 years)
Biomarker assessment and genetic screening help contextualize why some patients achieve results at lower doses while others require escalation
So my interest in GLP-1 for lymphedema is really a natural outgrowth of my entire career helping patients with breast cancer and lymphedema
